FI851682L - Kloningsvektor. - Google Patents

Kloningsvektor.

Info

Publication number
FI851682L
FI851682L FI851682A FI851682A FI851682L FI 851682 L FI851682 L FI 851682L FI 851682 A FI851682 A FI 851682A FI 851682 A FI851682 A FI 851682A FI 851682 L FI851682 L FI 851682L
Authority
FI
Finland
Prior art keywords
kloningsvektor
Prior art date
Application number
FI851682A
Other languages
English (en)
Finnish (fi)
Other versions
FI851682A7 (fi
FI851682A0 (fi
Inventor
Keith C Backman
Original Assignee
Bioteknika International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioteknika International filed Critical Bioteknika International
Publication of FI851682A0 publication Critical patent/FI851682A0/fi
Publication of FI851682A7 publication Critical patent/FI851682A7/fi
Publication of FI851682L publication Critical patent/FI851682L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI851682A 1984-04-30 1985-04-29 Kloningsvektor. FI851682L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/605,488 US4673640A (en) 1984-04-30 1984-04-30 Regulated protein production using site-specific recombination

Publications (3)

Publication Number Publication Date
FI851682A0 FI851682A0 (fi) 1985-04-29
FI851682A7 FI851682A7 (fi) 1985-10-31
FI851682L true FI851682L (fi) 1985-10-31

Family

ID=24423877

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851682A FI851682L (fi) 1984-04-30 1985-04-29 Kloningsvektor.

Country Status (7)

Country Link
US (1) US4673640A (de)
EP (1) EP0160571A3 (de)
JP (1) JPS60244291A (de)
AU (1) AU4179385A (de)
DK (1) DK191085A (de)
FI (1) FI851682L (de)
IL (1) IL75026A0 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900669A (en) * 1984-04-30 1990-02-13 Biotechnica International, Inc. Dual-stage fermentation
US5498600A (en) * 1984-10-12 1996-03-12 Zymogenetics, Inc. Biologically active mosaic proteins
US4889919A (en) * 1986-08-13 1989-12-26 Zymogenetics, Inc. Biologically active PDGF derived A-chain homodimers
US5187263A (en) * 1984-10-12 1993-02-16 Zymogenetics, Inc. Expression of biologically active PDGE analogs in eucaryotic cells
EP0487116B1 (de) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
US5045633A (en) * 1985-02-25 1991-09-03 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
CA1293460C (en) * 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
KR960015610B1 (ko) * 1987-06-22 1996-11-18 제네틱스 인스티튜트, 인코포레이티드 신규의 혈전붕괴 단백질의 제조방법
US5227288A (en) * 1990-10-01 1993-07-13 Blattner Frederick R DNA sequencing vector with reversible insert
US5834202A (en) 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US5614389A (en) * 1992-08-04 1997-03-25 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
FR2715940B1 (fr) * 1994-02-10 1996-04-26 Pasteur Merieux Serums Vacc Procédé de préparation d'une banque multicombinatoire de vecteurs d'expression de gènes d'anticorps, banque et systèmes d'expression d'anticorps "coliclonaux" obtenus.
US6825012B2 (en) * 1995-02-23 2004-11-30 Gencell S.A. DNA molecules, preparation and use in gene therapy
US6720140B1 (en) * 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
EP2322614A1 (de) * 1995-06-07 2011-05-18 Life Technologies Corporation Rekombinatorische Klonierung unter Verwendung genmanipulierter Rekombinationsorte
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
US7351578B2 (en) * 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US20030124555A1 (en) * 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
EP1025217B1 (de) * 1997-10-24 2006-10-04 Invitrogen Corporation Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US6333449B1 (en) 1998-11-03 2001-12-25 Plant Genetic Systems, N.V. Glufosinate tolerant rice
EP1173460B1 (de) * 1999-03-02 2009-09-16 Life Technologies Corporation Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
EP1159402A4 (de) * 1999-03-02 2003-01-29 Invitrogen Corp ZELLEN, WELCHE RESISTENT GEGENüBER TOXISCHEN GENEN SIND UND DEREN ANWENDUNGEN
GB9921937D0 (en) * 1999-09-17 1999-11-17 Univ Leeds Targeted gens removal
NZ539430A (en) 1999-12-10 2006-09-29 Invitrogen Corp Use of multiple recombination sites with unique specificity in recombinational cloning
US7244560B2 (en) * 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
EP1354035B1 (de) 2001-01-26 2016-08-24 Commonwealth Scientific and Industrial Research Organisation Verfahren und mittel zur herstellung eines wirksamen silencing-konstrukts mit rekombinationsklonierung
JP2004531259A (ja) * 2001-04-19 2004-10-14 インヴィトロジェン コーポレーション 核酸分子の組換えクローニングのための組成物および方法
WO2002096923A1 (en) * 2001-05-30 2002-12-05 Chromos Molecular Systems, Inc. Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
HUP0402659A3 (en) * 2001-05-30 2008-07-28 Glaxo Group Ltd Chromosome-based platforms
JP2005521400A (ja) 2002-03-29 2005-07-21 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 植物におけるラムダインテグラーゼ媒介型組換え
US20040204953A1 (en) * 2002-07-17 2004-10-14 Lincoln Muir Subscription based systems, methods and components for providing genomic and proteomic products and services
EP1546395A4 (de) * 2002-07-26 2007-05-02 Genecopoeia Inc Verfahren und nukleinsäurevektoren zur schnellen expression und zum schnellen screening von cdna-klonen
WO2005028615A2 (en) * 2003-06-26 2005-03-31 Invitrogen Corporation Methods and compositions for detecting promoter activity and expressing fusion proteins
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US7935862B2 (en) 2003-12-02 2011-05-03 Syngenta Participations Ag Targeted integration and stacking of DNA through homologous recombination
US20080184380A1 (en) * 2004-10-22 2008-07-31 Therapeutic Human Polyclonals Inc. Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals
WO2007110695A2 (en) * 2005-10-13 2007-10-04 Bc Cancer Agency Modular genomes for synthetic biology and metabolic engineering
CN118165942B (zh) * 2024-03-22 2024-12-13 青岛润达生物科技有限公司 一株沙门氏菌噬菌体rdp-sa-22022及其连续化生产工艺和应用

Also Published As

Publication number Publication date
EP0160571A2 (de) 1985-11-06
DK191085D0 (da) 1985-04-29
DK191085A (da) 1985-10-31
IL75026A0 (en) 1985-08-30
FI851682A7 (fi) 1985-10-31
AU4179385A (en) 1985-12-05
FI851682A0 (fi) 1985-04-29
EP0160571A3 (de) 1987-08-19
US4673640A (en) 1987-06-16
JPS60244291A (ja) 1985-12-04

Similar Documents

Publication Publication Date Title
DE3583455D1 (de) Salbenbase.
DE3581430D1 (de) Detergens.
DE3585265D1 (de) Fibronektinpraeparate.
FI77959B (fi) Hushaolls- eller motsvarande koeksanordning.
DE3581707D1 (de) Neigungsmesser.
DE3583080D1 (de) Mikrorechner.
DE3578421D1 (de) Glycidyloxydiketone.
DE3582060D1 (de) Homopropargylamine.
FI73926B (fi) Standardhastighetsregulator foer motorfordon.
DE3584628D1 (de) Xenocoumacine.
DE3577708D1 (de) Diphenylhexafluorpropanabkoemmlinge.
DE3586085D1 (de) Antitumor-4-hydroxy-2-zyklopentenonen.
FI840466A7 (fi) Lyftkil.
FI80907B (fi) Kraftunderstoedd hudappliseringsapparat.
DE3574867D1 (de) Aminokarnitine.
DE3587711D1 (de) Minaktivin.
DE3574494D1 (de) Selbstzerlegerzuender.
FI83368B (fi) Handelvapen.
FI853865A0 (fi) Oevningsmaol.
FI854602L (fi) Sammandragande tandvaordsmedel.
DE3576291D1 (de) Entaester.
DE3574593D1 (de) Hexahydroindolizinone.
DE3585189D1 (de) Alpha-d-mannosidase hemmungsmittel.
FI73513B (fi) Spiralsammanfogat ventilationsroer.
DE3587308D1 (de) Monobactame.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BIOTECHNICA INTERNATIONAL, INC.